| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $15,636,171 | 10 | 100 |
| Busch Matthew C. | VP, Finance & CAO | 0 | $0 | 1 | $375,790 | $-375,790 |
| Miller Derek | SVP, Human Resources | 0 | $0 | 1 | $733,033 | $-733,033 |
| Grygiel Nancy A. | SVP & CCO | 0 | $0 | 3 | $1.36M | $-1.36M |
| Khosla Rachna | SVP, Business Development | 0 | $0 | 3 | $1.65M | $-1.65M |
| Gordon Murdo | EVP, Global Commercial Ops | 0 | $0 | 1 | $2.32M | $-2.32M |
| Santos Esteban | EVP, Operations | 0 | $0 | 1 | $9.21M | $-9.21M |
Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples include Enbrel, prescribed for …
Over the last 12 months, insiders at Amgen Inc. have bought $0 and sold $15.64M worth of Amgen Inc. stock.
On average, over the past 5 years, insiders at Amgen Inc. have bought $0 and sold $11.16M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 6,020 shares for transaction amount of $1M was made by Hassan Fred (director) on 2015‑08‑19.
| 2026-08-13 | Sale | Khosla Rachna | SVP, Business Development | 1,252 0.0002% | $416.43 | $521,365 | +1.98% | |
| 2026-08-11 | Sale | Khosla Rachna | SVP, Business Development | 2,000 0.0004% | $412.57 | $825,134 | +2.65% | |
| 2026-08-06 | Sale | Miller Derek | SVP, Human Resources | 1,821 0.0003% | $402.54 | $733,033 | +4.30% | |
| 2026-08-06 | Sale | Grygiel Nancy A. | SVP & CCO | 1,000 0.0002% | $402.16 | $402,160 | +4.30% | |
| 2026-05-04 | Sale | Grygiel Nancy A. | SVP & CCO | 1,237 0.0002% | $323.73 | $400,451 | +19.69% | |
| 2026-02-26 | Sale | Santos Esteban | EVP, Operations | 24,291 0.0045% | $379.12 | $9.21M | -2.71% | |
| 2026-02-19 | Sale | Busch Matthew C. | VP, Finance & CAO | 1,000 0.0002% | $375.79 | $375,790 | -1.43% | |
| 2025-11-20 | Sale | Grygiel Nancy A. | SVP & CCO | 1,639 0.0003% | $337.26 | $552,773 | +8.48% | |
| 2025-11-12 | Sale | Gordon Murdo | EVP, Global Commercial Ops | 6,879 0.0013% | $336.83 | $2.32M | +7.41% | |
| 2025-11-12 | Sale | Khosla Rachna | SVP, Business Development | 890 0.0002% | $336.24 | $299,256 | +7.41% | |
| 2025-08-20 | Sale | Grygiel Nancy A. | SVP & CCO | 1,267 0.0002% | $296.99 | $376,280 | +17.21% | |
| 2025-06-05 | Sale | Khosla Rachna | SVP, Business Development | 1,500 0.0003% | $289.68 | $434,520 | +15.87% | |
| 2025-05-02 | Sale | Busch Matthew C. | VP, Finance & CAO | 1,000 0.0002% | $279.69 | $279,690 | +9.84% | |
| 2025-02-21 | Sale | REESE DAVID M | EVP & Chief Technology Officer | 25,225 0.0048% | $304.44 | $7.68M | -0.71% | |
| 2025-02-19 | Sale | Santos Esteban | EVP, Operations | 8,711 0.0016% | $292.84 | $2.55M | +2.24% | |
| 2025-02-19 | Sale | REESE DAVID M | EVP & Chief Technology Officer | 8,711 0.0016% | $293.22 | $2.55M | +2.24% | |
| 2025-02-19 | Sale | Miller Derek | SVP, Human Resources | 1,524 0.0003% | $293.74 | $447,655 | +2.24% | |
| 2025-02-18 | Sale | Miller Derek | SVP, Human Resources | 500 <0.0001% | $292.56 | $146,279 | +2.75% | |
| 2025-02-11 | Sale | Gordon Murdo | EVP, Global Commercial Ops | 8,771 0.0016% | $294.79 | $2.59M | +1.82% | |
| 2025-02-07 | Sale | Graham Jonathan P | EVP & Gen. Counsel & Secy. | 25,045 0.0046% | $293.12 | $7.34M | +2.88% |
| Bradway Robert A | Chairman, CEO and President | 383102 0.0709% | $176.71M | 1 | 2 | +39.21% |
| MORROW GEORGE J | Exe VP, Global Commercial Ops | 93719 0.0173% | $43.23M | 1 | 4 | <0.0001% |
| CHOATE JERRY D | director | 48575 0.009% | $22.41M | 1 | 2 | <0.0001% |
| GLUCK FREDERICK W | director | 15748 0.0029% | $7.26M | 1 | 3 | <0.0001% |
| de Carbonnel Francois | director | 15528 0.0029% | $7.16M | 2 | 4 | +16.14% |
| COFFMAN VANCE D | director | 10668 0.002% | $4.92M | 1 | 0 | <0.0001% |
| Hassan Fred | director | 3582 0.0007% | $1.65M | 1 | 0 | <0.0001% |
| HERRINGER FRANK C | director | 2000 0.0004% | $922,520.00 | 2 | 0 | +3.74% |
$1,927,310,793 | 31 | 28.02% | $1,325.87B | |
$364,368,632 | 29 | 9.65% | $36.8B | |
$6,224,380 | 25 | 3.58% | $640.75B | |
$23,541,811 | 22 | 6.43% | $126.14B | |
$28,542,809 | 19 | 26.39% | $505.4B |
| Increased Positions | 1,606 | +55.34% | 27M | +6.26% |
| Decreased Positions | 1,255 | -43.25% | 16M | -3.85% |
| New Positions | 384 | New | 4M | New |
| Sold Out Positions | 106 | Sold Out | 1M | Sold Out |
| Total Postitions | 3,253 | +12.1% | 439M | +2.42% |
| Vanguard Group Inc | $17.65M | 10.01% | 53.88M | +165,281 | +0.31% | 2025-09-30 |
| Blackrock, Inc. | $15.08M | 8.56% | 46.03M | -563,906 | -1.21% | 2025-09-30 |
| State Street Corp | $9.6M | 5.45% | 29.3M | -52,933 | -0.18% | 2025-09-30 |
| Capital International Investors | $6.29M | 3.57% | 19.19M | +282,219 | +1.49% | 2025-09-30 |
| Capital World Investors | $6.16M | 3.49% | 18.8M | +2M | +11.48% | 2025-09-30 |
| Morgan Stanley | $5.21M | 2.96% | 15.91M | -274,256 | -1.7% | 2025-09-30 |
| Charles Schwab Investment Management Inc | $4.44M | 2.52% | 13.55M | +656,935 | +5.09% | 2025-09-30 |
| Geode Capital Management, Llc | $4.35M | 2.47% | 13.27M | +248,898 | +1.91% | 2025-09-30 |
| Primecap Management Co/Ca/ | $3.18M | 1.8% | 9.71M | -924,100 | -8.69% | 2025-09-30 |
| Wells Fargo & Company/Mn | $2.35M | 1.33% | 7.16M | -153,586 | -2.1% | 2025-09-30 |